One of the more common questions surrounding anesthesia billing is whether there is any meaningful value in increasing gross charges annually when most reimbursement is not directly tied to charges. Unlike many other specialties, anesthesia reimbursement is generally calculated using a unit-based methodology rather than a percentage of billed charges. Medicare and most managed care payers reimburse anesthesia services using a formula based on base units, time units, modifiers and a contracted conversion factor—not the submitted charge amount itself.
Because of this reimbursement structure, organizations often ask whether annual increases to anesthesia fee schedules are still necessary. While annual charge increases may not significantly change reimbursement from contracted payers, there are still several important financial, strategic, and compliance-related reasons to continue reviewing and updating anesthesia charges on a routine basis.
Why Charge Increases Still Matter
Although anesthesia reimbursement is typically conversion-factor driven, gross charges continue to play an important role within the overall revenue cycle and contracting environment. Payers frequently evaluate the relationship between billed charges and reimbursement levels when assessing contract performance, market competitiveness and future negotiations. Organizations that leave anesthesia charges unchanged for extended periods may gradually become misaligned with market benchmarks and peer organizations.
Additionally, while most anesthesia contracts are not percentage-of-charge based, there are still scenarios in which gross charges directly affect reimbursement outcomes. Workers’ compensation claims, out-of-network/commercial accounts, stop-loss provisions, carve-out arrangements and certain legacy percentage-of-charge contracts may still rely heavily on the billed amount submitted by the provider. In these situations, maintaining current charge structures helps protect reimbursement integrity and reduces the risk of payment erosion over time.
Inflationary Pressures Continue to Impact Anesthesia Services
Another major reason organizations continue annual fee schedule reviews is the rising cost associated with delivering anesthesia care. Healthcare organizations continue to experience increasing expenses related to staffing shortages, wage growth, malpractice premiums, pharmaceuticals, anesthesia supplies, compliance obligations and technology investments.
Even though reimbursement contracts may not increase proportionately, many organizations believe fee schedules should still reasonably reflect the cost of delivering care. Revenue integrity and chargemaster guidance routinely support ongoing charge maintenance as part of sound financial stewardship and pricing governance.
What Inflation Rate Is Typically Used?
There is no universally required inflation factor for anesthesia charge increases, but most organizations rely on common healthcare inflationary benchmarks when determining annual adjustments. Frequently used references include:
- Consumer Price Index (CPI)
- Medical Care CPI
- Medicare Economic Index (MEI)
- Regional market benchmarking
In practice, most annual anesthesia fee schedule increases generally fall within the range of approximately 2%–5% annually. Organizations facing substantial labor or operational cost increases may justify higher adjustments, while others may apply more modest increases simply to maintain market alignment and preserve a defensible pricing structure.
The Growing Importance of Defensible Pricing
The healthcare industry’s continued focus on price transparency and regulatory oversight has increased the importance of maintaining current and defensible charge structures. Organizations are increasingly expected to demonstrate active governance over pricing methodologies and chargemaster maintenance. A fee schedule that has remained static for many years may create avoidable questions during audits, payer negotiations, compliance reviews and price transparency assessments.
Even within a predominantly conversion-factor reimbursement environment, annual anesthesia fee schedule reviews remain an important best practice for revenue integrity, payer strategy, market alignment and compliance governance.
IDR and the Increasing Importance of Charge Integrity
Another emerging consideration is the impact of the federal No Surprises Act independent dispute resolution (IDR) process. Under the current IDR framework, providers and payers may enter arbitration when out-of-network reimbursement disputes cannot be resolved. While the Qualifying Payment Amount (QPA) remains a major consideration in the process, providers often submit additional documentation intended to support the appropriateness of their proposed reimbursement rates, including historical contracting patterns, market conditions, case complexity and provider billing practices.
In this environment, maintaining a well-governed and consistently updated anesthesia charge structure becomes increasingly important. Although billed charges alone are not intended to determine the IDR outcome, an outdated or artificially low charge per unit may weaken the overall presentation of market value and reimbursement reasonableness during disputes. Conversely, organizations that can demonstrate routine annual review and rational charge escalation tied to inflationary pressures, operational costs and market benchmarking are often in a stronger position to defend the credibility of their reimbursement expectations.
A practical internal policy statement may read as follows:
The anesthesia fee schedule is reviewed annually to maintain market alignment, support payer negotiations, reflect inflationary increases in the cost of care delivery, preserve reimbursement integrity for charge-based payment methodologies and maintain a current and defensible charge structure.
In summation, reviewing and appropriately revising the group’s charge rates can have a material impact on the group’s overall financial integrity.